Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Roxee Meds Catalog

Maropitant

Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.

Both Catalog complete FDA data linked Rx required Tablet Multiple FDA sponsors Official label facts Owner quick guide first
Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Data freshness

Storefront facts
Catalog refreshed
Apr 22, 2026, 10:07 a.m.

These are the storefront facts Roxee uses on browse cards and quick facts.

FDA applications
FDA application data refreshed
May 5, 2026, 10:00 a.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports
Safety data refreshed
May 5, 2026, 10:01 a.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details
Source timing details
  • Storefront facts: Source Roxee | Refreshed Apr 22, 2026, 10:07 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC

Evidence

Reviewed / Updated / Sources

Reviewed by: Not available

Last reviewed: April 15, 2026

Updated: April 15, 2026, 10:04 AM UTC

Sources:
Image coming soon
Maropitant

Maropitant

Drug type: Generic ingredient • Generic profile • No FDA branded products linked

Both Tablet Rx required 100% storefront ready

Species: Both

Manufacturer: Multiple FDA sponsors

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Maropitant

For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age: Species commonly shown: Both, Dog, No Use Class Stated Or Implied, Cat, No Use Class Stated Or Implied.

Generic name
Maropitant
Brand names
Cerenia® Tablets, Cerenia® Injectable Solution, Maropitant Citrate, Maropitant Citrate Tablets
Manufacturer
Multiple FDA sponsors
Species
Both, Dog, No Use Class Stated Or Implied, Cat, No Use Class Stated Or Implied
Dosage forms
Tablet, Liquid (Solution), Injectable Solution, Chewable Tablets
Prescription
Prescription required
Completeness
100%
Validation
Complete
Brand names
Cerenia® Tablets Cerenia® Injectable Solution Maropitant Citrate Maropitant Citrate Tablets
Dosage forms
Tablet Liquid (Solution) Injectable Solution Chewable Tablets

Indications / Uses

For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:

Warnings / Contraindications

For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

  • For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

Side Effects

Top reported reactions (openFDA): Vomiting, Diarrhoea, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurological'), Lethargy (see also Central nervous system depression in Neurological), Not eating.

FAQ

Both, Dog, No Use Class Stated Or Implied, Cat, No Use Class Stated Or Implied

Yes. Roxee shows this as prescription-only.

Tablet, Liquid (Solution), Injectable Solution, Chewable Tablets

Related Conditions

Acute vomiting Gastrointestinal (additional)

Source Transparency

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

  • For oral use in dogs only
  • CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg)
  • The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins
  • The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens
  • wobbly/unsteady walking (1 reports)
  • Loss of appetite (1 reports)
  • Behavioral disorder (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

Regulatory restrictions are shown in Vet View.

What to tell or ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs

Side effects to monitor:

  • For oral use in dogs only
  • CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg)
  • The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins
  • The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens
  • wobbly/unsteady walking

Most reported reactions:

  • Unsteady walking (ataxia) (1 reports)
  • Loss of appetite (1 reports)
  • Behavioral disorder (unspecified) (1 reports)

Emergency warning signs:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Multiple FDA sponsors
Form: Chewable Tablets, Injectable Solution, Liquid (Solution), Tablet
Identifiers:
ANADA: 200710 ANADA: 200747 ANADA: 200785 ANADA: 200833 NADA: 141262 NADA: 141263 NDC Package: 11695-7029-1 NDC Package: 11695-7029-2 NDC Package: 11695-7030-1 NDC Package: 11695-7030-2 NDC Package: 11695-7031-1 NDC Package: 11695-7031-2 NDC Package: 11695-7032-1 NDC Package: 11695-7032-2 NDC Package: 11695-7054-1 NDC Package: 11695-7054-2 NDC Package: 11695-7055-1 NDC Package: 11695-7055-2 NDC Package: 11695-7056-1 NDC Package: 11695-7056-2
Source metadata:

Warnings / Contraindications

For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

  • High: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
27
Species represented
2
Grouped by Body System
Digestive (1) · Loss of appetite Skin & allergy (1) · Hair loss at application site Neurologic (1) · Unsteady walking (ataxia) Behavior (2) · Behavioral disorder (unspecified), Anxiety Other (27) · Bilirubinuria, Basophilia, Bacterial skin infection NOS
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Neurologic 1 Dog 1
Digestive 1 Cat 1
Behavior 1 Dog 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1
Other 1 Cat 1

Species coverage: Dog (16) Cat (16)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Dog Serious - 1
Digestive Cat Serious - 1
Skin & allergy Cat Non-serious - 1
Other Dog Non-serious - 1
Behavior Dog Serious - 1
Other Cat Serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Non-serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Behavior Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Serious - 1
Other Dog Serious - 1
Other Dog Serious - 1
Source metadata:

Documents

Owner handouts and official technical documents open on-page first, with the original source still one click away.

Owner handouts

0
No owner handouts linked yet.

Official label / PI

0
No official label or package insert links yet.

SPL

6

FOI

10

Maropitant Citrate Tablets

SPL · SPL

Open original
FDA Structured Product Label

Maropitant Citrate Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Felix Pharmaceuticals Pvt. Ltd.
ANADA
200-833
Status
RX
Form
Chewable Tablets
Route
Oral
Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant as maropitant citrate per tablet

Dogs

Indication

For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.

Dosage

For Prevention of Acute Vomiting in dogs 2 - 7 months of age: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.

Maropitant Citrate

SPL · SPL

Open original
FDA Structured Product Label

Maropitant Citrate

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Dechra Veterinary Products LLC
ANADA
200-710
Status
RX
Form
Injectable Solution
Route
Intravenous, Subcutaneous
Composition / specifications
Each mL contains 10 mg of maropitant as maropitant citrate

Dogs

Indication

For the prevention and treatment of acute vomiting.

Dosage

Administer 1.0 mg per kilogram (mg/kg) of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.

Cats

Indication

For the treatment of vomiting.

Dosage

Administer 1.0 mg/kg of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.

Maropitant Citrate Tablets

SPL · SPL

Open original
FDA Structured Product Label

Maropitant Citrate Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Felix Pharmaceuticals Pvt. Ltd.
ANADA
200-785
Status
RX
Form
Tablet
Route
Oral
Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant citrate per tablet

Dogs

Indication

For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.

Dosage

For Prevention of Acute Vomiting in dogs 2 -7 months of age: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.

For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.

For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.

Maropitant Citrate

SPL · SPL

Open original
FDA Structured Product Label

Maropitant Citrate

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
ZYVET AH, Inc.
ANADA
200-747
Status
RX
Form
Tablet
Route
Oral
Species
Dog, No Use Class Stated Or Implied
Composition / specifications
16, 24, 60, or 160 mg of maropitant as maropitant citrate per tablet

Dogs (2-7 months of age)

Indication

For prevention of acute vomiting.

Dosage

Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.

Dogs (7 months of age and older)

Indication

For prevention of acute vomiting.

Dosage

Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.

Dogs (4 months of age and older)

Indication

For prevention of vomiting due to motion sickness.

Dosage

Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.

Cerenia® Tablets

SPL · SPL

Open original
FDA Structured Product Label

Cerenia® Tablets

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Zoetis Inc.
NADA
141-262
Status
RX
Form
Tablet
Route
Oral
Species
Dog, No Use Class Stated Or Implied
Composition / specifications
Each tablet contains 16, 24, 60, or 160 milligrams (mg) maropitant as maropitant citrate.

Dogs (7 Months of Age and Older)

Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
Limitations
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Dogs (4 Months of Age and Older)

Indication
For the prevention of vomiting due to motion sickness.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days
Limitations
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg).

Dogs (2-7 Months)

Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days
Limitations
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Cerenia® Injectable Solution

SPL · SPL

Open original
FDA Structured Product Label

Cerenia® Injectable Solution

Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.

Sponsor
Zoetis Inc.
NADA
141-263
Status
RX
Form
Liquid (Solution)
Route
Subcutaneous, Intravenous
Species
Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 10 milligrams (mg) maropitant as maropitant citrate.

Dogs (2-4 Months of Age)

Indication
For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:
Dosage
Administer subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

Dogs (4 Months of Age and Older)

Indication
For Prevention of Vomiting in Dogs 4 months of Age and Older Caused by Emetogenic Medications or Chemotherapeutic Agents.
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) of body weight one time, 45-60 minutes prior to use of emetogenic medications or chemotherapeutic agents.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Indication
For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/1 kg (1 mL/22 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

Cats (4 Months of Age and Older)

Indication
For Treatment of Vomiting in Cats 4 Months of Age and Older
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

FOI Summary oA 200-833 Approved January 12, 2026.pdf

FOI · FOI

Open original

FOI Summary oA 200-710 Approved December 5, 2025.pdf

FOI · FOI

Open original

FOI Summary oA 200-785 Approved June 17, 2024.pdf

FOI · FOI

Open original

FOI Summary oA 200-747 Approved March 31, 2023.pdf

FOI · FOI

Open original

UCM453543.pdf

FOI · FOI

Open original

UCM050060.pdf

FOI · FOI

Open original

UCM484493.pdf

FOI · FOI

Open original

UCM314823.pdf

FOI · FOI

Open original

UCM314825.pdf

FOI · FOI

Open original

ucm062313.pdf

FOI · FOI

Open original
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Storefront facts: Source Roxee | Refreshed Apr 22, 2026, 10:07 AM UTC
    The storefront fact projection used for browse cards and quick facts.
  • Animal Drugs @ FDA: Source FDA | Refreshed May 5, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Official (FDA)
Identity: Generic ingredient • No FDA branded products linked
No official FDA brand rows linked yet for this ingredient.
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Cat, Dog
Rx/OTC: RX
Form/route: Chewable Tablets, Injectable Solution, Liquid (Solution), Tablet • Intravenous, Oral, Subcutaneous
Applications: ANADA 200-833 • ANADA 200-710 • ANADA 200-785 • ANADA 200-747 • NADA 141-262 • NADA 141-263
Documents: 10 (FOI: 10) • SPL: 6 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 261 • Cat 195 • View
Case summaries: 89 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points
  • For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens. (Contraindication, High)
Top reaction signals
Unsteady walking (ataxia) (1) Loss of appetite (1) Behavioral disorder (unspecified) (1) Basophilia (1) Azotaemia (1) Ascites (1) Arrhythmia (1) Application site reaction NOS (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
ANADA: 200710 ANADA: 200747 ANADA: 200785 ANADA: 200833 NADA: 141262 NADA: 141263 NDC Package: 11695-7029-1 NDC Package: 11695-7029-2 NDC Package: 11695-7030-1 NDC Package: 11695-7030-2 NDC Package: 11695-7031-1 NDC Package: 11695-7031-2 NDC Package: 11695-7032-1 NDC Package: 11695-7032-2 NDC Package: 11695-7054-1 NDC Package: 11695-7054-2 NDC Package: 11695-7055-1 NDC Package: 11695-7055-2 NDC Package: 11695-7056-1 NDC Package: 11695-7056-2 NDC Package: 11695-7057-1 NDC Package: 11695-7057-2 NDC Package: 13612-0035-0 NDC Package: 13612-0035-1
Package NDC Product NDC Form / Route Status
11695-7029-1 11695 -
11695-7029-2 11695 -
11695-7030-1 11695 -
11695-7030-2 11695 -
11695-7031-1 11695 -
11695-7031-2 11695 -
11695-7032-1 11695 -
11695-7032-2 11695 -
11695-7054-1 11695 -
11695-7054-2 11695 -
11695-7055-1 11695 -
11695-7055-2 11695 -
11695-7056-1 11695 -
11695-7056-2 11695 -
11695-7057-1 11695 -
11695-7057-2 11695 -
13612-0035-0 13612 -
13612-0035-1 13612 -
17033-004-01 17033 -
17033-006-04 17033 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 29 Clinical 9 Manufacturer 0 Marketing 0
Current Field Facts
  • contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Clinical, 2026-04-15)
  • contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Clinical, 2026-04-15)
  • contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Clinical, 2026-04-11)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
  • monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
  • side_effects: Top reported reactions (openFDA): Vomiting, Diarrhoea, Death by euthanasia, Lethargy (see also Central nervous system depression in 'Neurological'), Lethargy (… (Clinical, 2026-04-11)
  • usage: For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 M… (Clinical, 2026-04-15)
  • usage: For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 M… (Clinical, 2026-04-15)
  • usage: For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 M… (Clinical, 2026-04-11)
  • contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Official, 2026-04-22)
  • contraindications: For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restric… (Official, 2026-02-12)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-05-05)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-05-03)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-05-02)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-04-29)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-04-28)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-04-27)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-04-26)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-04-25)
  • indications: Dogs:Â For the prevention and treatment of acute vomiting.Cats:Â For the treatment of vomiting. For the prevention and treatment of acute vomiting in dogs. For… (Official, 2026-04-22)
Recent Revisions
  • side_effects updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-22 10:07 by etl_backfill • Backfilled from existing medication fields
  • monitoring updated 2026-04-16 13:28 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-16 13:28 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-16 13:28 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-16 13:28 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-16 13:28 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-16 13:28 by curated_loader • Official FDA application reference for Senvelgo.
  • side_effects updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-04-15 10:07 by etl_backfill • Backfilled from existing medication fields
  • monitoring updated 2026-04-15 10:07 by curated_loader • Clinical monitoring context for feline diabetes management.
  • usage updated 2026-04-15 10:07 by curated_loader • Usage statement from FDA warning letter and approved-product context.
  • drug_profile_type updated 2026-04-15 10:07 by curated_loader • FDA source confirms Senvelgo as a branded approved product.
  • manufacturer_name updated 2026-04-15 10:07 by curated_loader • FDA warning letter identifies the approved sponsor/manufacturer.
  • brand_names updated 2026-04-15 10:07 by curated_loader • FDA warning letter references Senvelgo as the approved animal drug.
  • approval_reference updated 2026-04-15 10:07 by curated_loader • Official FDA application reference for Senvelgo.
  • side_effects updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields
  • contraindications updated 2026-04-15 10:04 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Maropitant Citrate Tablets
RX
Maropitant
Chewable Tablets • Oral
Label highlights
Official documents
Felix Pharmaceuticals Pvt. Ltd. ANADA 200-833 Approved Feb 2, 2026
Maropitant Citrate
RX
Maropitant
Injectable Solution • Intravenous, Subcutaneous
Label highlights
Official documents
Dechra Veterinary Products LLC ANADA 200-710 Approved Jan 5, 2026
Maropitant Citrate Tablets
RX
Maropitant
Tablet • Oral
Label highlights
Official documents
Felix Pharmaceuticals Pvt. Ltd. ANADA 200-785 Approved Jul 1, 2024
Maropitant Citrate
RX
Maropitant
Tablet • Oral
Label highlights
Official documents
ZYVET AH, Inc. ANADA 200-747 Approved Mar 31, 2023
Cerenia® Tablets
RX
Maropitant
Tablet • Oral
Label highlights
Official documents
Zoetis Inc. NADA 141-262 Approved Jan 31, 2019
Cerenia® Injectable Solution
RX
Maropitant
Liquid (Solution) • Subcutaneous, Intravenous
Label highlights
Official documents
Zoetis Inc. NADA 141-263 Approved Jun 1, 2016

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant as maropitant citrate per tablet
Dogs
Indication

For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.

Dosage

For Prevention of Acute Vomiting in dogs 2 - 7 months of age: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.
For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer Maropitant Citrate Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.

Limitations

FDA page: Open in Animal Drugs @ FDA

Composition / specifications
Each mL contains 10 mg of maropitant as maropitant citrate
Dogs
Indication

For the prevention and treatment of acute vomiting.

Dosage

Administer 1.0 mg per kilogram (mg/kg) of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.

Limitations
Cats
Indication

For the treatment of vomiting.

Dosage

Administer 1.0 mg/kg of body weight by subcutaneous or intravenous injection once daily for up to 5 consecutive days.

Limitations

FDA page: Open in Animal Drugs @ FDA

Composition / specifications
16 mg, 24 mg, 60 mg, or 160 mg of maropitant citrate per tablet
Dogs
Indication

For the prevention of acute vomiting and the prevention of vomiting due to motion sickness in dogs.

Dosage

For Prevention of Acute Vomiting in dogs 2 -7 months of age: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.

For Prevention of Acute Vomiting in dogs 7 months of age and older: Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.

For Prevention of Vomiting due to motion sickness in dogs 4 months of age and older: Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
16, 24, 60, or 160 mg of maropitant as maropitant citrate per tablet
Dogs (2-7 months of age)
Indication

For prevention of acute vomiting.

Dosage

Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days.

Limitations
Dogs (7 months of age and older)
Indication

For prevention of acute vomiting.

Dosage

Administer orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.

Limitations
Dogs (4 months of age and older)
Indication

For prevention of vomiting due to motion sickness.

Dosage

Administer orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days.

Limitations

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
Each tablet contains 16, 24, 60, or 160 milligrams (mg) maropitant as maropitant citrate.
Dogs (7 Months of Age and Older)
Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily until resolution of acute vomiting.
Limitations
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dogs (4 Months of Age and Older)
Indication
For the prevention of vomiting due to motion sickness.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 8 mg/kg (3.6 mg/lb) body weight once daily for up to 2 consecutive days
Limitations
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg).
Dogs (2-7 Months)
Indication
For the prevention of acute vomiting.
Dosage
Administer CERENIA Tablets orally at a minimum dose of 2 mg/kg (0.9 mg/lb) body weight once daily for up to 5 consecutive days
Limitations
For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

FDA page: Open in Animal Drugs @ FDA

Species: Dog, No Use Class Stated Or Implied • Cat, No Use Class Stated Or Implied
Composition / specifications
Each milliliter of solution contains 10 milligrams (mg) maropitant as maropitant citrate.
Dogs (2-4 Months of Age)
Indication
For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:
Dosage
Administer subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Dogs (4 Months of Age and Older)
Indication
For Prevention of Vomiting in Dogs 4 months of Age and Older Caused by Emetogenic Medications or Chemotherapeutic Agents.
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) of body weight one time, 45-60 minutes prior to use of emetogenic medications or chemotherapeutic agents.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Indication
For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/1 kg (1 mL/22 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.
Cats (4 Months of Age and Older)
Indication
For Treatment of Vomiting in Cats 4 Months of Age and Older
Dosage
Administer intravenously over 1-2 minutes or subcutaneously at 1 mg/kg (0.45 mg/lb) equal to 0.1 mL/kg (0.1 mL/2.2 lb) of body weight once daily for up to 5 consecutive days.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

FDA page: Open in Animal Drugs @ FDA

Usage

For the prevention of acute vomiting. For the prevention of vomiting due to motion sickness. For Prevention and Treatment of Acute Vomiting in Dogs: Dogs 2-4 Months of Age:

Source: FDA Animal Drugs @ FDA • Reference

Contraindications

For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For oral use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. CERENIA injectable solution should not be used interchangeably with CERENIA tablets for the prevention of vomiting due to motion sickness (8mg/kg). Federal law restricts this drug to use by or on the order of a licensed veterinarian. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats with gastrointestinal obstruction or that have ingested toxins. The safe use of CERENIA Injectable Solution has not been evaluated in dogs or cats used for breeding, or in pregnant or lactating bitches or queens.

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Digestive
Loss of appetite (1) • Cat

Showing top 5 for Digestive.

Skin & allergy
Hair loss at application site (1) • Cat

Showing top 5 for Skin & allergy.

Neurologic
Unsteady walking (1) • Dog

Showing top 5 for Neurologic.

Behavior
Behavioral disorder (1) • Dog Anxiety (1) • Dog

Showing top 5 for Behavior.

Other
Bilirubinuria (1) • Dog Basophilia (1) • Cat Bacterial skin infection NOS (1) • Dog Azotaemia (1) • Cat Ascites (1) • Cat
Show more (22)
Arthritis (1) • Cat Arrhythmia (1) • Cat Application site reaction NOS (1) • Cat Application site pain (1) • Cat Application site erythema (1) • Cat Application site crust (1) • Cat Angioedema (1) • Dog Anaphylaxis (1) • Cat Anaemia NOS (1) • Dog Allergic reaction (1) • Dog Agitation (1) • Dog Agglutination test, positive (1) • Dog Adipsia (1) • Cat Accidental exposure (1) • Cat Abnormal ultrasound finding (1) • Dog Abnormal tail posture (1) • Dog Abnormal radiograph finding (1) • Cat Abnormal posture NOS (1) • Dog Abnormal histology NOS (1) • Dog Abnormal cytology (1) • Cat Abdominal pain (1) • Dog Abdominal discomfort (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Persian, Male, 12.5 year, 4.4 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 0.44 mL per animal, Frequency: 6 per day • Reactions: Intentional misuse, Lack of efficacy - NOS, Death by euthanasia, Gait abnormality, Lumbar pain • Outcome: Euthanized

  • Report ID: USA-USFDACVM-2025-US-075165
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 12.50 Year
  • Weight: 4.400 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection
  • Dose: 0.44 mL per animal
  • Frequency: 6 per day
Reactions Reported:
Intentional misuse Lack of efficacy - NOS Death by euthanasia Gait abnormality Lumbar pain
Outcomes: Euthanized

Dog, Chihuahua, Male, 12 year, 3.084 kilogram • Drug: MSK, Tablet, Unknown • Reactions: Seizure NOS, Lateral recumbency, Unresponsive to stimuli, Bradycardia • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-075262
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 12.00 Year
  • Weight: 3.084 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Tablet
Reactions Reported:
Seizure NOS Lateral recumbency Unresponsive to stimuli Bradycardia
Outcomes: Recovered/Normal

Dog, Siberian Husky, Male, 9 year, 21.682 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 2.20 mL per animal • Reactions: Injection site lesion, Crust, Injection site ulcer, Injection site erythema, Injection site discharge NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075214
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 9.00 Year
  • Weight: 21.682 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Injection
  • Dose: 2.20 mL per animal
Reactions Reported:
Injection site lesion Crust Injection site ulcer Injection site erythema Injection site discharge NOS
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 15 year, 3.302 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Elevated symmetrical dimethylarginine, Elevated creatinine, Elevated serum alkaline phosphatase, Weight loss, Accidental exposure… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075358
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 15.00 Year
  • Weight: 3.302 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Form: Unassigned
Reactions Reported:
Elevated symmetrical dimethylarginine Elevated creatinine Elevated serum alkaline phosphatase Weight loss Accidental exposure Anaemia NOS
Outcomes: Ongoing

Cat, Domestic Shorthair, Female, 7 month, 3.08 kilogram • Drug: MSK, Unknown • Reactions: Fever, Cough, productive, Weight loss, Breathing difficulty, Abnormal radiograph finding… • Outcome: Recovered/Normal

  • Report ID: USA-USFDACVM-2025-US-075237
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Female
  • Age: 7.00 Month
  • Weight: 3.080 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Fever Cough, productive Weight loss Breathing difficulty Abnormal radiograph finding Pulmonary disorder NOS Tiredness (lethargy) Sedation Kidney atrophy Bilirubinuria Elevated mean corpuscular haemoglobin concentration Enlarged kidney Elevated mean corpuscular volume Eosinopenia Low serum alkaline phosphatase Neutropenia Discoloured urine Monocytosis Lymphopenia Elevated amylase Elevated alanine aminotransferase Low creatinine Hyponatremia Other abnormal test result NOS Elevated total bilirubin Hyperglycaemia Lymphocytosis Neutrophilia Leucocytosis NOS Basophilia
Outcomes: Recovered/Normal

Dog, ['Retriever - Golden', 'Beagle', 'Chow Chow'], Male, 11 year, 19.504 kilogram • Drug: MSK, Tablet, Oral • Reactions: Unsteady walking (ataxia), Vestibular disorder NOS, Weight loss, Head tilt - neurological disorder, Low vision… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075189
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 11.00 Year
  • Weight: 19.504 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Tablet
Reactions Reported:
Unsteady walking (ataxia) Vestibular disorder NOS Weight loss Head tilt - neurological disorder Low vision Urinary incontinence Unable to rise Urinary tract infection Polydipsia Horizontal nystagmus Generalised weakness Depression
Outcomes: Ongoing

Dog, Setter - Irish Red, Male, 9 year, 38 kilogram • Drug: MSK, Tablet, Oral, Dose: 80 Milligram per dose, Frequency: 24 per hour • Reactions: Inappetence, Elevated liver enzymes NOS, Tiredness (lethargy), Polydipsia, Polyuria… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-075441
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 9.00 Year
  • Weight: 38.000 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Oral
  • Form: Tablet
  • Dose: 80 Milligram per dose
  • Frequency: 24 per hour
Reactions Reported:
Inappetence Elevated liver enzymes NOS Tiredness (lethargy) Polydipsia Polyuria Icterus
Outcomes: Ongoing

Dog, Retriever - Labrador, Male, 11.08 year, 30.5 kilogram • Drug: MSK, Unknown • Reactions: Ear infection NOS, Loss of appetite, Nausea, Vomiting, Polycythaemia… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-074697
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 11.08 Year
  • Weight: 30.500 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Ear infection NOS Loss of appetite Nausea Vomiting Polycythaemia Elevated haemoglobin Increased percentage reticulocytes Elevated mean corpuscular volume Elevated alanine aminotransferase Elevated serum alkaline phosphatase Elevated gamma-glutamyl transferase Elevated cholesterol Hyperproteinaemia Elevated total bilirubin Elevated blood urea nitrogen Abnormal ultrasound finding Abnormal histology NOS Other abnormal test result NOS
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.